Zhanjun Ma

2.4k total citations · 2 hit papers
56 papers, 1.7k citations indexed

About

Zhanjun Ma is a scholar working on Surgery, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Zhanjun Ma has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 18 papers in Molecular Biology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Zhanjun Ma's work include Spine and Intervertebral Disc Pathology (7 papers), MicroRNA in disease regulation (6 papers) and Scoliosis diagnosis and treatment (6 papers). Zhanjun Ma is often cited by papers focused on Spine and Intervertebral Disc Pathology (7 papers), MicroRNA in disease regulation (6 papers) and Scoliosis diagnosis and treatment (6 papers). Zhanjun Ma collaborates with scholars based in China and Belgium. Zhanjun Ma's co-authors include Xuewen Kang, Xuegang He, Guangzhi Zhang, Yicheng Gao, Yubao Lu, Wenzhao Liu, Xuexi Wang, Jingjing Yang, Jie-Ru Li and Mingqiang Liu and has published in prestigious journals such as Biomaterials, International Journal of Molecular Sciences and International Journal of Pharmaceutics.

In The Last Decade

Zhanjun Ma

52 papers receiving 1.7k citations

Hit Papers

NF‐κB signalling pathways in nucleus pulposus cell functi... 2021 2026 2022 2024 2021 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhanjun Ma China 23 743 521 287 277 258 56 1.7k
Mahesh Thirunavukkarasu United States 30 1.1k 1.5× 389 0.7× 305 1.1× 239 0.9× 103 0.4× 72 2.5k
Jun Lü China 29 974 1.3× 512 1.0× 514 1.8× 283 1.0× 272 1.1× 93 2.4k
Xuewen Kang China 20 706 1.0× 702 1.3× 260 0.9× 209 0.8× 355 1.4× 79 1.7k
Constanze Buhrmann Germany 33 1.5k 2.0× 212 0.4× 354 1.2× 547 2.0× 373 1.4× 50 3.5k
Qianqian Liang China 26 965 1.3× 238 0.5× 208 0.7× 154 0.6× 275 1.1× 124 2.6k
Chun‐Hay Ko Hong Kong 30 1.1k 1.5× 256 0.5× 125 0.4× 265 1.0× 475 1.8× 88 2.6k
Guanwei Fan China 32 1.2k 1.7× 271 0.5× 345 1.2× 224 0.8× 248 1.0× 77 2.7k
Ying Nie China 30 1.2k 1.6× 145 0.3× 270 0.9× 258 0.9× 199 0.8× 91 2.6k
Jihee Lee Kang South Korea 37 1.2k 1.6× 127 0.2× 237 0.8× 376 1.4× 163 0.6× 98 3.1k
Jung‐Hyun Kim South Korea 29 1.4k 1.8× 120 0.2× 234 0.8× 254 0.9× 132 0.5× 94 2.5k

Countries citing papers authored by Zhanjun Ma

Since Specialization
Citations

This map shows the geographic impact of Zhanjun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanjun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanjun Ma more than expected).

Fields of papers citing papers by Zhanjun Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanjun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanjun Ma. The network helps show where Zhanjun Ma may publish in the future.

Co-authorship network of co-authors of Zhanjun Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanjun Ma. A scholar is included among the top collaborators of Zhanjun Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanjun Ma. Zhanjun Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Zhanjun, Bernard Učakar, Nicolas Joudiou, et al.. (2025). Repurposing Chemotherapeutics in a Hyaluronic Acid-conjugate Combination Treatment Approach for the Local Immunomodulation of the Glioblastoma Microenvironment. International Journal of Pharmaceutics. 676. 125612–125612. 2 indexed citations
3.
Liu, Wenzhao, Zhanjun Ma, & Xuewen Kang. (2022). Current status and outlook of advances in exosome isolation. Analytical and Bioanalytical Chemistry. 414(24). 7123–7141. 105 indexed citations
4.
Chang, Xingyu, et al.. (2021). New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma. Journal of bone oncology. 29. 100372–100372. 54 indexed citations
5.
Zhang, Guangzhi, Yajun Deng, Xuegang He, et al.. (2021). Different Types of Double-Level Degenerative Lumber Spondylolisthesis: What Is Different in the Sagittal Plane?. World Neurosurgery. 150. e127–e134. 3 indexed citations
6.
Yang, Jingjing & Zhanjun Ma. (2021). Research progress on the effects of nickel on hormone secretion in the endocrine axis and on target organs. Ecotoxicology and Environmental Safety. 213. 112034–112034. 29 indexed citations
7.
Yang, Kai, et al.. (2020). Expression and distribution of HIF-1α, HIF-2α, VEGF, VEGFR-2 and HIMF in the kidneys of Tibetan sheep, plain sheep and goat. Folia Morphologica. 79(4). 748–755. 5 indexed citations
8.
Ma, Zhanjun, Yubao Lu, Fengguang Yang, et al.. (2020). Rosmarinic acid exerts a neuroprotective effect on spinal cord injury by suppressing oxidative stress and inflammation via modulating the Nrf2/HO-1 and TLR4/NF-κB pathways. Toxicology and Applied Pharmacology. 397. 115014–115014. 74 indexed citations
9.
Ma, Zhanjun, Jingjing Yang, Yubao Lu, Zhaoyang Liu, & Xuexi Wang. (2020). Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine. World Journal of Stem Cells. 12(8). 814–840. 84 indexed citations
10.
Lu, Yubao, Jingjing Yang, Xuexi Wang, et al.. (2020). Research progress in use of traditional Chinese medicine for treatment of spinal cord injury. Biomedicine & Pharmacotherapy. 127. 110136–110136. 46 indexed citations
11.
Ma, Zhanjun, Jingjing Yang, Yang Yang, et al.. (2020). Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway. Phytomedicine. 68. 153186–153186. 59 indexed citations
13.
Lü, Li, Guohu Chen, Jingjing Yang, et al.. (2019). Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K/AKT signaling pathway. Biomedicine & Pharmacotherapy. 112. 108625–108625. 56 indexed citations
14.
Ma, Zhanjun, Yan Hu, Yang Yang, et al.. (2018). Proteomics analysis demonstrating rosmarinic acid suppresses cell growth by blocking the glycolytic pathway in human HepG2 cells. Biomedicine & Pharmacotherapy. 105. 334–349. 20 indexed citations
15.
Ma, Zhanjun, Lu Li, Jingjing Yang, et al.. (2017). Lariciresinol induces apoptosis in HepG2 cells via mitochondrial-mediated apoptosis pathway. European Journal of Pharmacology. 821. 1–10. 100 indexed citations
16.
Ma, Zhanjun, Kangquan Shou, Zonghuan Li, et al.. (2016). Negative pressure wound therapy promotes vessel destabilization and maturation at various stages of wound healing and thus influences wound prognosis. Experimental and Therapeutic Medicine. 11(4). 1307–1317. 35 indexed citations
17.
18.
Zhu, Yongchao, Weibiao Liao, Lijuan Niu, Meng Wang, & Zhanjun Ma. (2016). Nitric oxide is involved in hydrogen gas-induced cell cycle activation during adventitious root formation in cucumber. BMC Plant Biology. 16(1). 146–146. 47 indexed citations
19.
Ma, Zhanjun, Xuexi Wang, Gang Su, et al.. (2016). Proteomic analysis of apoptosis induction by lariciresinol in human HepG2 cells. Chemico-Biological Interactions. 256. 209–219. 16 indexed citations
20.
Ma, Zhanjun. (2011). The clinical application of Glucocorticoids(GC). China Modern Medicine. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026